01 Jun 2021

Update on SARS-CoV-2 Antigen Lateral Flow Test Regulatory Submissions

Diagnostics | Investors

28 May 2021

Response to speculation

Diagnostics | Investors

25 May 2021

Posting of Annual Report and Notice of AGM

Investors

10 May 2021

AffiDX^® SARS-CoV-2 Antigen Lateral Flow Test Update

Diagnostics | Investors